Gastrointestinal Surgery (all articles)
Guideline | Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts.
26 Nov, 2021 | 09:41h | UTC
Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution from a Prospective, Randomized Controlled Multicenter Trial.
26 Nov, 2021 | 09:42h | UTC
Guideline | Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract.
26 Nov, 2021 | 09:39h | UTC
Clinical practice guideline for the treatment of malignant ascites.
25 Nov, 2021 | 10:28h | UTC
Review: The value of systematic reviews and meta-analyses in surgery.
25 Nov, 2021 | 10:11h | UTCThe Value of Systematic Reviews and Meta-Analyses in Surgery – European Surgical Research
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.
23 Nov, 2021 | 08:40h | UTC
Commentary on Twitter (thread – click for more)
⭐️NEW @AmCollegeGastro guidelines on #GERD!⭐️
🔥 🤭 🌶 💊 ✂️
"A lot has changed, much remains the same." 🧵 ⬇️#MedTwitter #GITwitter #GI #motility #MedEd https://t.co/HS26GDk8Jd
— John Damianos, M.D. (@john_damianosMD) November 22, 2021
RCT: Educating outpatients for bowel preparation before colonoscopy using virtual reality videos improved bowel preparation, polyp and adenoma detection rates, and improved compliance and satisfaction.
23 Nov, 2021 | 08:28h | UTC
Commentary on Twitter
RCT finds patients who received virtual reality video education before a colonoscopy had better bowel preparation, higher polyp and adenoma detection rates, and improved compliance and satisfaction. https://t.co/dAUtFf2m4B pic.twitter.com/RKAVZcVGuy
— JAMA Network Open (@JAMANetworkOpen) November 22, 2021
Bowel Perforation: ED presentations, evaluation, and management.
23 Nov, 2021 | 08:19h | UTCBowel Perforation: ED presentations, evaluation, and management – emDocs
Consensus Statement: U.S. Multi-Society Task Force on Colorectal Cancer now suggests average-risk CRC screening begins at age 45.
21 Nov, 2021 | 23:01h | UTCRelated:
State of the Art Review: Screening and prevention of colorectal cancer.
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Clinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding.
21 Nov, 2021 | 22:44h | UTCClinical Guideline Highlights for the Hospitalist: Management of Upper Gastrointestinal and Ulcer Bleeding – Journal of Hospital Medicine (free for a limited period)
Long-term results of RCT: Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer.
19 Nov, 2021 | 10:15h | UTCChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Author Interview: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Commentary on Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
Nursing care for oncologic patients undergoing surgery using an enhanced recovery approach.
17 Nov, 2021 | 08:22h | UTCOncologic Surgical Care Using an Enhanced Recovery Approach – AACN Advanced Critical Care
News release: Enhanced Recovery Approach Changes Care for Surgical Oncology Patients – American Association of Critical-Care Nurses
Related: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
RCT: Adjustable intragastric balloon resulted in significant weight loss at 32 weeks, but intolerance caused early removal of the device in 17% of patients, and device-related serious adverse events were observed in 4% of patients.
17 Nov, 2021 | 08:26h | UTCAdjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
In this trial, when an adjustable intragastric balloon was combined with lifestyle modification in adults with obesity, significant weight loss was achieved and maintained for 6 months following device removal. https://t.co/jg7z5ldeC7 #GITwitter pic.twitter.com/Pi9PVAeWzo
— The Lancet (@TheLancet) November 16, 2021
Review and algorithm: Dysphagia aortica.
16 Nov, 2021 | 08:19h | UTCDysphagia aortica – European Surgery
Cohort study suggests low-dose vs. standard radiation dose CT have similar diagnostic accuracy in suspected acute appendicitis.
14 Nov, 2021 | 19:37h | UTCNews release: Doctors can use CT scans with less radiation to diagnose appendicitis – Oxford University
Original study: Diagnostic accuracy using low-dose versus standard radiation dose CT in suspected acute appendicitis: prospective cohort study – British Journal of Surgery (link to abstract – $ for full-text)
Cohort study: In patients with nonalcoholic steatohepatitis and obesity, bariatric surgery was associated with lower risk of incident major adverse liver outcomes and major adverse cardiovascular events.
12 Nov, 2021 | 10:24h | UTCAssociation of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (free for a limited period)
Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (free for a limited period)
Commentary on Twitter
Study found, among patients with nonalcoholic steatohepatitis and obesity, bariatric surgery, vs nonsurgical management, was associated with a significantly lower risk of incident major adverse liver outcomes and major adverse cardiovascular events https://t.co/Ps23yfjncq
— JAMA (@JAMA_current) November 11, 2021
Among patients with cancer who received decompressive G-tubes for nutrition or malignant bowel obstruction, nearly half presented with stage IV disease and died within one month of placement.
12 Nov, 2021 | 09:55h | UTCCommentary: Risks and Benefits Associated With Gastrostomy Tubes for Patients With Cancer – The ASCO Post
RCT: One-time flexible sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality.
10 Nov, 2021 | 07:04h | UTCCommentaries:
Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors.
9 Nov, 2021 | 01:04h | UTC
Commentary on Twitter
#Neuroendocrine tumors are heterogeneous with a complex treatment landscape. This #JCOOP Clinical Review discusses optimal management of #NET and key patient/tumor characteristics that can guide treatment selection https://t.co/zZF36E93w8 pic.twitter.com/2xqwOlwIvw
— Journal of Clinical Oncology (@JCO_ASCO) October 28, 2021
A cohort study with 287 patients showed that those who fulfill 5 criteria 2 or 3 days after laparoscopic colorectal surgery (a CRP below 150 mg/dL, a return of bowel function, tolerance of a diet, little pain, and afebrile during the entire stay) have a low risk of developing an anastomotic leak. These criteria have the potential to allow for safe early discharge.
7 Nov, 2021 | 20:06h | UTCAssessing Criteria for a Safe Early Discharge After Laparoscopic Colorectal Surgery – JAMA Surgery (free for a limited period)
Commentary on Twitter
A prospective observational study on 287 adults showing that patients with CRP<150mg/dL, bowel function, diet tolerance, pain<5/10 and no fever, 2-3 days after laparoscopic colorectal surgery have a low anastomotic leak risk and may be discharged early https://t.co/zq8lvHPoQ1
— JAMA Surgery (@JAMASurgery) November 5, 2021
M-A: Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
7 Nov, 2021 | 20:07h | UTC
Review: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation.
3 Nov, 2021 | 09:45h | UTC
Commentary on Twitter
New content online: Management of alcohol use disorder in patients with cirrhosis in the setting of liver transplantation https://t.co/sWd1Vs6N2c pic.twitter.com/XZo8ETzhEl
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) November 2, 2021
Short Review: Metronidazole-induced neurotoxicity.
2 Nov, 2021 | 02:41h | UTCMetronidazole-induced neurotoxicity – Canadian medical Association Journal
Commentary on Twitter
The ability of metronidazole to cause neurotoxicity is not widely appreciated. Here's our quick overview led by @DanicaQuickfall, just out in @CMAJ.
https://t.co/7sggYzCzGN pic.twitter.com/miW0trFuYv— David Juurlink (@DavidJuurlink) October 25, 2021
Review: Clinical management of pancreatic premalignant lesions.
31 Oct, 2021 | 19:56h | UTCClinical Management of Pancreatic Premalignant Lesions – Gastroenterology
AGA Clinical Practice Update on Endoscopic Management of Perforations in Gastrointestinal Tract.
27 Oct, 2021 | 01:35h | UTC


